BBP ETF holdings (NYSE) - Page 3 | MetaTrader

Ver el calendario completo Full chart

Visión general Todos los activos Mapa de calor

Activos clave Market Value Shares Weight %

ZLAB Zai Lab Ltd 638.4 K 38.5 K 1.4%

ACAD ACADIA Pharmaceuticals Inc 632.5 K 25.2 K 1.4%

KALV KalVista Pharmaceuticals Inc 630.9 K 40.4 K 1.4%

AUPH Aurinia Pharmaceuticals Inc 626.5 K 43.1 K 1.4%

RYTM Rhythm Pharmaceuticals Inc 616.9 K 6 017.0 1.4%

HRMY Harmony Biosciences Holdings I 616.1 K 16.9 K 1.4%

APLS Apellis Pharmaceuticals Inc 611.6 K 27.1 K 1.4%

TVTX Travere Therapeutics Inc 610.0 K 19.6 K 1.4%

NBIX NEUROCRINE BIOSCIENCES INC 608.5 K 4 472.0 1.4%

IMCR Immunocore Holdings PLC 604.4 K 18.6 K 1.3%

CRSP CRISPR Therapeutics AG 602.3 K 12.1 K 1.3%

ESPR Esperion Therapeutics Inc 601.8 K 177.5 K 1.3%

ADMA ADMA Biologics Inc 597.7 K 34.6 K 1.3%

ARQT Arcutis Biotherapeutics Inc 597.4 K 23.5 K 1.3%

LENZ LENZ Therapeutics Inc 596.0 K 37.7 K 1.3%

BCRX BioCryst Pharmaceuticals Inc 594.0 K 90.3 K 1.3%

MDGL Madrigal Pharmaceuticals Inc 584.2 K 1 194.0 1.3%

ALNY Alnylam Pharmaceuticals Inc 580.4 K 1 717.0 1.3%

INSM Insmed Inc 544.0 K 3 468.0 1.2%

KURA Kura Oncology Inc 543.0 K 66.9 K 1.2%

1
2
3
4

Noticias

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies

ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)